Digital Health Resources

Disease Management Solution Brochure

Rev up your Patient Support Program with our Disease Management Solution

Enhance the patient journey for at-home subcutaneous injections

CSL Behring: Supporting hemophilia B patients on a journey toward a life-changing gene therapy treatment

Frost & Sullivan names BrightInsight its 2023 IoT Healthcare Solutions Global Company of the Year

BrightInsight + Claritas Rx: Abandonment and discontinuation variation in specialty drugs

Go-to-market strategies for patient-facing digital health solutions

Remote patient monitoring to simplify risk evaluation and mitigation strategy (REMS) protocols

Patient companion apps + remote patient monitoring for MS

Building a digital health platform that scales

Crafting an RFP to find the right SaMD partner

RFP configuration tool: Find the right digital health partner

Digital disease management for migraine

Revolutionizing disease management for Alzheimer's through digital

Digital disease management in solid tumor oncology

Disease management in hematological oncology

Digital disease management in rheumatoid arthritis

10 questions to ask your potential SaMD platform partner

5 questions medtech leaders are asking

How digital disease management delivers value for biopharma

Expectation vs. reality: Cost and time to bring SaMD to market

By the numbers: Cost and time to bring SaMD to market

CSL Behring: Targeting improvements in patient adoption and retention

Disease Management Solution Patient App technical sheet

Disease Management Solution Healthcare Provider Interfaces technical sheet

Disease Management Solution Analytics Dashboards technical sheet

Treatment selection in autoimmune: How digital can unlock opportunities for biopharma

BrightInsight Overview Brochure

Novo Nordisk: Digital Health Solutions to Improve Diabetes Care

BrightInsight provides a unified IoT platform that enables Novo Nordisk to develop and host digital health devices, apps and algorithms.

Biopharma Use Cases

From patient diagnosis and treatment selection algorithms to disease management, BrightInsight can support your regulated digital health use cases.

4 Ways Digital Can Transform Treatment Selection in Oncology

How Biopharma Commercial and R&D Can Partner to Accelerate Digital Innovation

How biopharma commercial and R&D can partner to accelerate digital innovation

The Role of Digital Health in Immuno-oncology Therapy Development and Adoption

The Role of Digital Health in Immuno-oncology Therapy Development and Adoption

Harnessing the Power of Cloud Computing in Medtech

Why a Successful Digital Health Product Launch Starts with a Regulated IoT Infrastructure

Regulatory Roadmap for Digital Health Products

Survey Results: Biopharma Leaders Share COVID-19's Impact on Digital Health

Frost & Sullivan Names BrightInsight its 2020 Global Entrepreneurial Company of the Year

How to launch regulated software as a medical device in 6 months’ time

How an unregulated IoT platform increases your risk and delays time to market

10 Questions CEOs Should Be Asking About their IoT Platform Strategy

3 digital health considerations for connected device or software as a medical device leaders

How Biopharma and Medtech CISOs Can Minimize Risk in Today’s Digital Era

How BrightInsight Solves your Top Digital Challenges

Accelerating Clinical Trials with Digital Health

Biopharma and Medtech CIOs: How to Succeed in Today's Digital Era

The evolving role of the biopharma and medtech CIO: How to succeed in today's digital era

How BrightInsight Solves your Top IT Challenges

How Biopharma and Medtech Can Successfully Engage Payers in Support of Digital Health

Connected Diagnostics Platform

Connected Diagnostics Platform Technical Sheets

Leveraging connected diagnostics to deliver value to IVD manufacturers